Karex Bhd

Karex Bhd OCF Margin

The Operating Cash Flow Margin of Karex Bhd (KAREX.KL) as of Nov 13, 2026 is 5.73 %. In the previous year, Operating Cash Flow Margin was 14.00 % — a change of -59.05% (lower).

OCF Margin

5.73 %

YoY

-59.05%

Last updated:

Operating Cash Flow Margin of Karex Bhd is 2025 5.73 % . Operating Cash Flow Margin of Karex Bhd was 2024 14.00 % . It decreases by -59.05% lower compared to the previous year.

The Karex Bhd OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
0.81 MYR
Jan 1, 2019
8.53 MYR
Jan 1, 2020
7.09 MYR
Jan 1, 2021
3.86 MYR
Jan 1, 2022
0.13 MYR
Jan 1, 2023
1.31 MYR
Jan 1, 2024
14.00 MYR
Jan 1, 2025
5.73 MYR
The Karex Bhd OCF Margin history
YEAROCF MarginYoY
5.73 %-59.05%
14.00 %+968.89%
1.31 %+904.10%
0.13 %-96.62%
3.86 %-45.59%
7.09 %-16.84%
8.53 %+957.63%
0.81 %-84.75%
5.29 %-58.48%
12.73 %-16.16%
15.19 %+30.55%
11.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Karex Bhd Stock analysis

What does Karex Bhd do? Karex Bhd. generates revenue through its Sexual Wellness and Medical segments. The Sexual Wellness segment sells condoms, personal lubricants, and sex toys, while the Medical segment offers catheters, probe covers, HIV and pregnancy test kits, and other medical products. Products like greaseless, non-toxic lubrication jelly and specially designed probe covers for ultrasound examinations are key offerings. Sales occur across Malaysia, Thailand, the United States, and Europe, targeting healthcare providers, retailers, and consumers seeking sexual and medical wellness solutions. The company’s product portfolio includes condoms, lubrication jelly, probe covers, and foley balloon catheters, all manufactured and sold under its own brand. These items are distributed to medical facilities, pharmacies, and specialty retailers in key markets. The Medical segment’s HIV and pregnancy test kits cater to diagnostic needs, while the Sexual Wellness segment’s sex toys and lubricants address consumer health and intimacy requirements. The firm’s focus on rubber-based medical and wellness products ensures consistent demand in healthcare and personal care sectors. Karex Bhd. operates primarily in Malaysia, Thailand, the U.S., and Europe, serving both B2B and B2C markets. Its Medical segment supplies hospitals and clinics with catheters and test kits, while the Sexual Wellness segment targets direct consumer sales through retail channels. The company’s products are designed for safety and functionality, meeting regulatory standards for medical and personal use. Revenue streams are diversified across segments and geographies, supporting steady growth in global health and wellness markets. Karex Bhd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Karex Bhd stock

Operating Cash Flow Margin of Karex Bhd is 5.73 % in 2025.

Operating Cash Flow Margin of Karex Bhd changed from 14.00 % to 5.73 %, representing a -59.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Karex Bhd since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Karex Bhd with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Karex Bhd

All Key Metrics — Karex Bhd